Cargando…

Fibroblast function in COVID-19

Detalles Bibliográficos
Autores principales:	Sahin, Mustafa, Akkus, Erman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier GmbH. 2021
Materias:	Correspondences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849528/ https://www.ncbi.nlm.nih.gov/pubmed/33561763 http://dx.doi.org/10.1016/j.prp.2021.153353

Ejemplares similares

Comment on “Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management”
por: Sahin, Mustafa, et al.
Publicado: (2020)

Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
por: Hu, Jing-Yi, et al.
Publicado: (2021)

Branch Retinal Artery Occlusion in Patient with COVID-19: Case Report
por: Ateş, Orhan, et al.
Publicado: (2021)

Long-term effects of COVID-19 on kidney function
por: Delanaye, Pierre, et al.
Publicado: (2021)

Long-term effects of COVID-19 on kidney function
por: Enghard, Philipp, et al.
Publicado: (2021)

Balneotherapy and human immune function in the era of COVID-19
por: Masiero, Stefano, et al.
Publicado: (2020)

Functional exhaustion of antiviral lymphocytes in COVID-19 patients
por: Zheng, Meijuan, et al.
Publicado: (2020)

Normal RNAi response in human fragile × fibroblasts
por: Madsen, Charlotte, et al.
Publicado: (2009)

Anesthetic management for cesarean birth in pregnancy with the novel coronavirus (COVID-19)
por: Yilmaz, Resul, et al.
Publicado: (2020)

Long-term effects of COVID-19 on kidney function – Authors' reply
por: Huang, Lixue, et al.
Publicado: (2021)

Effects of fibroblast growth factor-2 on cell proliferation of cementoblasts
por: Yu, Hui-Chieh, et al.
Publicado: (2016)

Radiolabeled fibroblast activation protein inhibitors in the evaluation of myocardial fibrosis
por: Su, Xiangyu, et al.
Publicado: (2023)

Respirators used by healthcare workers due to the COVID-19 outbreak increase end-tidal carbon dioxide and fractional inspired carbon dioxide pressure
por: Özdemir, Levent, et al.
Publicado: (2020)

Lung Function Levels Influence the Association between Obesity and Risk of COVID-19
por: Bui, Dinh S., et al.
Publicado: (2021)

Reprogramming of fibroblasts to uterine glandular epithelium by a chemical cocktail induction
por: Yuan, Xuewei, et al.
Publicado: (2019)

Dihydroartemisinin-induced mitochondrial mRNA degradation and apoptosis in keloid fibroblasts
por: Li, Qijie, et al.
Publicado: (2022)

Fibroblast growth factor 21 is related to cisplatin resistance in ovarian cancer
por: Zhong, Qian, et al.
Publicado: (2022)

Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients
por: Taboada, Manuel, et al.
Publicado: (2021)

Correlation of respiratory muscle function and cardiopulmonary exercise testing in post-acute COVID-19 syndrome
por: Leo, Fabian, et al.
Publicado: (2022)

Fetuin-A, fibroblast growth factor 23 and inflammation in critically ill patients with sepsis
por: Fajol, Abul
Publicado: (2021)

COVID-19 Vasculopathy and Post–COVID-19 Phenomenon: Reply
por: Akgul, Ahmet
Publicado: (2021)

Left Ventricular Systolic Function and Inpatient Mortality in Patients Hospitalized with Coronavirus Disease 2019 (COVID-19)
por: Faridi, Kamil F., et al.
Publicado: (2020)

Reduced Cardiac Function by Echocardiography in a Minority of COVID-19 Patients 3 Months after Hospitalization
por: Tangen, Jorun, et al.
Publicado: (2022)

Mobile COVID-19 Screening Units: Heat Stress and Kidney Function Among Health Care Workers
por: Chang, Teng-Hsiang, et al.
Publicado: (2022)

Comment on: “Fibroblast growth factor 21 controls mitophagy and muscle mass” by Oost et al.
por: Wu, Yeshun, et al.
Publicado: (2019)

COVID-19 and Coagulopathy
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Cancer and COVID-19
por: Malek, Alexandre E, et al.
Publicado: (2020)

Cancer and COVID-19
por: Moris, Dimitrios, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Anticoagulation in COVID-19
por: Atallah, Bassam, et al.
Publicado: (2020)

Clozapine and COVID-19
por: Silva, Edward, et al.
Publicado: (2020)

Barotrauma and COVID-19
por: Hillman, Ken
Publicado: (2022)

The impact of lockdown on Functional Motor Disorders patients during the first COVID-19 outbreak: acase-control study
por: Di Vico, Ilaria A., et al.
Publicado: (2021)

Fighting COVID-19: The role of a COVID-19 Task Force Team
por: Park, Hayne Cho, et al.
Publicado: (2021)

COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?
por: Zhao, Yuhao, et al.
Publicado: (2021)

A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
por: Durak, Aysegul, et al.
Publicado: (2018)

Impending cognitive and functional decline in COVID-19 survivors. Comment on Br J Anaesth 2021; 126: 44–7
por: Magoon, Rohan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8rttvjq31afim0l9901m5ei2qc